JP2021522812A5 - - Google Patents
Info
- Publication number
- JP2021522812A5 JP2021522812A5 JP2020562704A JP2020562704A JP2021522812A5 JP 2021522812 A5 JP2021522812 A5 JP 2021522812A5 JP 2020562704 A JP2020562704 A JP 2020562704A JP 2020562704 A JP2020562704 A JP 2020562704A JP 2021522812 A5 JP2021522812 A5 JP 2021522812A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- seq
- binding protein
- tolerance
- immunogenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024203619A JP2025028927A (ja) | 2018-05-07 | 2024-11-22 | グリコフォリンａ抗原結合タンパク質 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862668132P | 2018-05-07 | 2018-05-07 | |
| US62/668,132 | 2018-05-07 | ||
| US201962805849P | 2019-02-14 | 2019-02-14 | |
| US62/805,849 | 2019-02-14 | ||
| US201962829920P | 2019-04-05 | 2019-04-05 | |
| US62/829,920 | 2019-04-05 | ||
| PCT/IB2019/053705 WO2019215590A1 (en) | 2018-05-07 | 2019-05-07 | Glycophorin a antigen-binding proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024203619A Division JP2025028927A (ja) | 2018-05-07 | 2024-11-22 | グリコフォリンａ抗原結合タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021522812A JP2021522812A (ja) | 2021-09-02 |
| JP2021522812A5 true JP2021522812A5 (https=) | 2022-05-16 |
Family
ID=66998454
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020562704A Pending JP2021522812A (ja) | 2018-05-07 | 2019-05-07 | グリコフォリンａ抗原結合タンパク質 |
| JP2024203619A Pending JP2025028927A (ja) | 2018-05-07 | 2024-11-22 | グリコフォリンａ抗原結合タンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024203619A Pending JP2025028927A (ja) | 2018-05-07 | 2024-11-22 | グリコフォリンａ抗原結合タンパク質 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220153859A1 (https=) |
| EP (1) | EP3790901A1 (https=) |
| JP (2) | JP2021522812A (https=) |
| WO (1) | WO2019215590A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| EP2603520A4 (en) * | 2010-08-10 | 2014-02-19 | Ecole Polytech | ERYTHROCYTE BINDING THERAPEUTICS |
| US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| SG11201606761RA (en) | 2014-02-21 | 2016-09-29 | Ecole Polytecnique Federale De Lausanne Epfl Epfl Tto | Glycotargeting therapeutics |
| CA3051839A1 (en) | 2017-02-17 | 2018-08-23 | Bristol-Myers Squibb Company | Antibodies to alpha-synuclein and uses thereof |
| WO2018232176A1 (en) | 2017-06-16 | 2018-12-20 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
| EP3790577A4 (en) | 2018-05-09 | 2022-04-27 | The University of Chicago | COMPOSITIONS AND METHODS RELATED TO IMMUNTOLERANCE |
| JP2025508740A (ja) * | 2022-02-17 | 2025-04-10 | アノキオン・ソシエテ・アノニム | 抗ａｓｇｒ１ポリペプチドおよび免疫寛容のための使用 |
| WO2025027015A1 (en) * | 2023-08-01 | 2025-02-06 | Diamante Srl | Composition and methods for treating multiple sclerosis |
| CN118388650B (zh) * | 2024-06-28 | 2024-08-27 | 杭州赛基生物科技有限公司 | 一种抗CD235a单克隆抗体及其制备方法和应用 |
| GB202412620D0 (en) * | 2024-08-28 | 2024-10-09 | Alivedx Suisse Sa | Diagnosis of coeliac disease |
| CN119350500B (zh) * | 2024-11-15 | 2026-02-27 | 浙江大学 | 抗CD235a单克隆抗体及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4752582A (en) * | 1982-12-17 | 1988-06-21 | The United States Of America As Represented By The United States Department Of Energy | Monoclonal antibodies to human glycophorin A and cell lines for the production thereof |
| CA2375115C (en) * | 1999-05-28 | 2011-05-24 | Stemcell Technologies Inc. | Method for separating cells using immunorosettes |
| WO2013121296A1 (en) * | 2012-02-15 | 2013-08-22 | Ecole Polytechnique Federale De Lausanne | Erythrocyte-binding therapeutics |
| US9517257B2 (en) * | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| WO2017015141A1 (en) * | 2015-07-17 | 2017-01-26 | President And Fellows Of Harvard College | Humanized anti-glycophorin a antibodies and uses thereof |
| US11104718B2 (en) * | 2016-11-16 | 2021-08-31 | Bayer Healthcare Llc | Red blood cell targeted factor VIII and method of using the same |
| KR102774451B1 (ko) * | 2017-11-14 | 2025-02-28 | 앱클론(주) | 항-her2 항체 또는 그의 항원 결합 단편, 및 이를 포함하는 키메라 항원 수용체 |
-
2019
- 2019-05-07 JP JP2020562704A patent/JP2021522812A/ja active Pending
- 2019-05-07 EP EP19732118.5A patent/EP3790901A1/en not_active Withdrawn
- 2019-05-07 WO PCT/IB2019/053705 patent/WO2019215590A1/en not_active Ceased
- 2019-05-07 US US17/052,954 patent/US20220153859A1/en not_active Abandoned
-
2024
- 2024-11-22 JP JP2024203619A patent/JP2025028927A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021522812A5 (https=) | ||
| JP2019527553A5 (https=) | ||
| JP2009517057A5 (https=) | ||
| RU2012107286A (ru) | Высокоаффинные человеческие антитела к человеческому ангиопоэтину-2 | |
| JP2020522513A5 (https=) | ||
| JP2010516229A5 (https=) | ||
| JP2020500508A5 (https=) | ||
| JP2018533973A5 (https=) | ||
| FI2897981T3 (fi) | Anti-CD3-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat CD3:a ja CD20:ta, ja niiden käyttöjä | |
| JP2006516409A5 (https=) | ||
| JP2009225799A5 (https=) | ||
| JP2018520668A5 (https=) | ||
| JP2017526370A5 (https=) | ||
| JP2018166506A5 (https=) | ||
| HRP20170374T1 (hr) | Biološki proizvodi | |
| RU2009120052A (ru) | Композиции и способы связывания сфингозин-1-фосфата | |
| JP2015530971A5 (https=) | ||
| RU2009140134A (ru) | Способы и композиции для лечения и мониторинга лечения связанных с ил-13 нарушений | |
| JP2015531768A5 (https=) | ||
| JP2013500941A5 (https=) | ||
| JP2006512899A5 (https=) | ||
| JP2010524435A5 (https=) | ||
| JP2016503293A5 (https=) | ||
| RU2009110154A (ru) | АНТИТЕЛА ПРОТИВ C5aR С УЛУЧШЕННЫМИ СВОЙСТВАМИ | |
| JP2017524362A5 (https=) |